Insider · CIK 0001352455
Jane Wasman
director
Files at RIGL (RIGEL PHARMACEUTICALS INC), SLS (SELLAS Life Sciences Group, Inc.). First filing Jun 2, 2025, latest Jun 2, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$34k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | SELLAS Life Sciences Group, Inc. | $34k 20,000 shares | +192% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | SLS SELLAS Life Sciences Group, Inc. | POpen-market purchase Common Stock | +20,000 | $1.69 | $34k | 30,400 | Jun 2, 2025 |
| May 23, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Common Stock | +2,500 | $0.00 | $0 | 12,500 | May 28, 2025 |
| May 23, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +3,000 | $0.00 | $0 | 3,000 | May 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.